Sarbjit Singh
University of Nebraska Medical Center, The University of Texas at Dallas, Guru Nanak Dev University, Dongguk University
Research areas: Medicine · Hematology · Chronic Lymphocytic Leukemia Research · Lymphoma Diagnosis and Treatment · Synthesis and biological activity
0000-0001-5719-967X
About
Sarbjit Singh was born in Amritsar, Punjab, India in 1981. He received his master’s and PhD degree in Organic chemistry under the supervision of Prof. Swapandeep Singh Chimni from Department of Chemistry, Guru Nanak Dev University, India. After completion of his PhD degree, he worked in Sphaera Pharma Pvt. Ltd. for one year and then moved to South Korea in 2013 to join Korea University as Research Professor. Later he joined Dongguk University in 2015 as an Assistant Professor. He moved to the USA in 2016 to join University of Texas at Dallas. Currently, he is working as Research Instructor in University of Nebraska Medical Center. His research interests include Medicinal Chemistry and methodology development.
Employment
-
University of Nebraska Medical Center Research Instructor2020 - Present
-
University of Nebraska Medical Center Postdoctoral Researcher2019 - 2020
-
University of Texas at Dallas Research Associate2016 - 2019
-
Dongguk University Assistant Professor2015 - 2016
-
Korea University Research Professor2013 - 2014
-
Sphaera Pharma Research Associate2012 - 2013
Education
-
Guru Nanak Dev University Doctorate2006 - 2012
-
Guru Nanak Dev University MSc (Hons)2003 - 2005
-
Guru Nanak Dev University Bsc (Hons)2000 - 2003
Projects & Funding
Projects & funding information is unavailable.
Publications (33)
- Surveying the Proteome-Wide Landscape of Mitoxantrone and Examining Drug Sensitivity in BRCA1-Deficient Ovarian Cancer Using Quantitative Proteomics Save
- A Selective MAP3K1 Inhibitor Facilitates Discovery of NPM1 as a Member of the Network Save
- Immunogenic Cell Death Traits Emitted from Chronic Lymphocytic Leukemia Cells Following Treatment with a Novel Anti-Cancer Agent, SpiD3 Save
- The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax Save
- Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive manner Save
- Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKK$β$ phosphorylation for pancreatic cancer therapy Save
- Synthesis and Biological Evaluation of 4/5-Aroyl-2-aminoimidazoles as Microbial Biofilm Inhibitors Save
- Fructose-1, 6-bisphosphatase Inhibitors: A Review of Recent (2000-2017) Advances and Structure-Activity Relationship Studies Save
- Analogues of epicatechin and related polyphenols Save
- Journey heading towards enantioselective synthesis assisted by organocatalysis Save
- Nanoagroceuticals & Nanophytochemicals Save
- Novel compound having HIV inhibitory activity and use thereof Save
- Discovery of a novel series of N-hydroxypyridone derivatives protecting astrocytes against hydrogen peroxide-induced toxicity via improved mitochondrial functionality Save
- A composition for preventing or treating melioidosis comprising hinokiresinol Save
- A Divergent Approach for the Synthesis of d - And l -4′-Ethynyl Dioxolane Nucleosides with Potent Anti-HIV Activity Save
- An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs Save
- Nucleosides with modified sugar ring: Synthesis and biological activities Save
- Recent advances in anticancer chemotherapeutics based upon azepine scaffold Save
- Recent advances in synthesis and antifungal activity of 1,3,5-triazines Save
- Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers Save